Detalhe da pesquisa
1.
Efficacy of high-dose versus standard-dose influenza vaccine in older adults.
N Engl J Med
; 371(7): 635-45, 2014 Aug 14.
Artigo
Inglês
| MEDLINE | ID: mdl-25119609
2.
Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older Adults.
Clin Infect Dis
; 62(9): 1092-1099, 2016 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26908801
3.
Antibody-mediated NK cell activation as a correlate of immunity against influenza infection.
Nat Commun
; 14(1): 5170, 2023 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-37620306
4.
Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model.
Vaccine
; 40(9): 1289-1298, 2022 02 23.
Artigo
Inglês
| MEDLINE | ID: mdl-35101265
5.
Reply to Skowronski et al.
Clin Infect Dis
; 63(9): 1267, 2016 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27506683
6.
Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6â¯months throughâ¯<18â¯years of age: A randomized controlled phase II dose-finding trial.
Vaccine
; 39(11): 1572-1582, 2021 03 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33610374
7.
Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models.
NPJ Vaccines
; 6(1): 61, 2021 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33875658
8.
Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza.
NPJ Vaccines
; 6(1): 153, 2021 Dec 16.
Artigo
Inglês
| MEDLINE | ID: mdl-34916519
9.
Safety and immunogenicity of high-dose quadrivalent influenza vaccine in adults ≥65â¯years of age: A phase 3 randomized clinical trial.
Vaccine
; 37(39): 5825-5834, 2019 09 16.
Artigo
Inglês
| MEDLINE | ID: mdl-31431411
10.
Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis.
Expert Rev Vaccines
; 18(3): 295-308, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30689467
11.
Gastrointestinal Events in High-Dose vs Standard-Dose Influenza Vaccine Recipients.
Open Forum Infect Dis
; 5(6): ofy115, 2018 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29942820
12.
Fluzone® Intradermal Quadrivalent Influenza Vaccine.
Expert Rev Vaccines
; 15(10): 1245-53, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27457797
13.
Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial.
Clin Vaccine Immunol
; 23(3): 228-35, 2016 Jan 13.
Artigo
Inglês
| MEDLINE | ID: mdl-26762363
14.
Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults.
Vaccine
; 33(9): 1151-9, 2015 Feb 25.
Artigo
Inglês
| MEDLINE | ID: mdl-25613721
15.
Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50-64 years of age.
Vaccine
; 33(51): 7188-7193, 2015 Dec 16.
Artigo
Inglês
| MEDLINE | ID: mdl-26555348
16.
Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty.
Vaccine
; 33(36): 4565-71, 2015 Aug 26.
Artigo
Inglês
| MEDLINE | ID: mdl-26187260
17.
Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines.
Vaccine
; 33(38): 4988-93, 2015 Sep 11.
Artigo
Inglês
| MEDLINE | ID: mdl-26212007
18.
Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial.
Vaccine
; 32(21): 2507-17, 2014 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24120672
19.
Safety and immunogenicity of an inactivated quadrivalent influenza vaccine in children 6 months through 8 years of age.
Pediatr Infect Dis J
; 33(6): 630-6, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24445833
20.
High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009-2010 season.
Vaccine
; 31(6): 861-6, 2013 Jan 30.
Artigo
Inglês
| MEDLINE | ID: mdl-23261045